Search
Explore Johnson Matthey's website
Showing results 821-840 / 1501
The elements of business
JM's Chief Technology Officer, Alan Nelson, looks at the vital contributions that elements make to major industries today.
ExploreThe elements of future energy
The hydrogen powered future is upon us. Preparing for it will require new technology – and chemistry is here to help, says JM's Jane Butcher, Sam French, Andy Walker and Barry Edmonstone-West.
ExploreCrystallisation process development
A whitepaper featuring a solid form expert, detailing crystallisation process development in the manufacture of active pharmaceutical ingredients (APIs)
ExploreUnlocking hydrogen’s potential
Taking a closer look at how hydrogen can support the transition to greener and cleaner energy.
ExploreDriving pharmaceutical innovation
JM's Vice President Innovator Products and Solutions, Nick Shackley, discusses advanced catalytic activity, combining technologies with collaborations and more.
ExploreOur shared history with the periodic table
JM's shared history with the periodic table of chemical elements and how our affiliation with it has developed over the years.
ExploreThe hydrogen opportunity
With a focus on the efficient use of natural resources, Johnson Matthey has developed a technology that could help to lower greenhouse gas emissions by improving process efficiency when producing hydrogen.
ExplorePropelling the maritime industry to sustainability with methanol
Expert insight: Sustainable methanol is emerging as a promising solution towards achieving ambitious emission reduction goals in the maritime industry.
ExploreThe elements of life: catalysing pharmaceutical innovation
JM's Ahir Pushpanath gives a fascinating insight into JM's developments in biocatalysis as he explores how enzymes' unique catalytic abilities drive science by connecting essential life elements.
ExploreThe importance of solid form science in modern drug development
As the pharmaceutical industry turns to more complex chemical entities with increased molecular weight, enhancing solubility is becoming a key drug development challenge.
ExploreHow Johnson Matthey’s eMERALD™ flowsheet makes e-methanol viable at scale
Enabling scalable, efficient and low-carbon methanol production.
ExploreComment on this morning's statement by Anglo Platinum
Comment on this morning's statement by Anglo Platinum
ExploreAnna Manz appointed as Group Finance Director of Johnson Matthey
Anna joins us from Diageo plc, a FTSE 10 global business, where she is currently Group Strategy Director and a member of Diageo’s Executive Committee
ExploreAGM trading update
First quarter sales in line with our expectations and guidance for the full year unchanged
ExploreActing to enhance the work-life balance and wellbeing of our people
JM has introduced three new global arrangements to improve the work-life balance of all its employees around the world.
Explore